Tushar Misra
Corporate Officer/Principal at MERSANA THERAPEUTICS, INC.
Net worth: 51 203 $ as of 2024-04-29
Tushar Misra active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MERSANA THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-08-15 | - |
Career history of Tushar Misra
Former positions of Tushar Misra
| Companies | Position | Start | End |
|---|---|---|---|
| WAVE LIFE SCIENCES LTD. | Corporate Officer/Principal | - | 2019-12-31 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 2006-07-31 | 2012-07-31 |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Laronde Inc. is a company that aims to advance eRNA-based therapeutics through their powerful new platform called endless RNA (eRNA™). The company is based in Cambridge, MA and was founded by Noubar B. Afeyan. This platform can be programmed to make any therapeutic protein inside the body, making it the most versatile RNA platform for life-changing medicines. | Corporate Officer/Principal | - | - |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Corporate Officer/Principal | 2014-09-30 | - |
Training of Tushar Misra
| National Institute of Technology | Undergraduate Degree |
| University of Rhode Island | Doctorate Degree |
Statistics
International
| United States | 6 |
| Singapore | 2 |
| India | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| WAVE LIFE SCIENCES LTD. | Health Technology |
| MERSANA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Commercial Services |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Laronde Inc. is a company that aims to advance eRNA-based therapeutics through their powerful new platform called endless RNA (eRNA™). The company is based in Cambridge, MA and was founded by Noubar B. Afeyan. This platform can be programmed to make any therapeutic protein inside the body, making it the most versatile RNA platform for life-changing medicines. | Commercial Services |
- Stock Market
- Insiders
- Tushar Misra
- Experience
